Skip to main content
Erschienen in: BMC Gastroenterology 1/2003

Open Access 01.12.2003 | Case report

Cystadenocarcinoma of the appendix: an incidental imaging finding in a patient with adenocarcinomas of the ascending and the sigmoid colon

verfasst von: Michail Pitiakoudis, Paraskevi I Argyropoulou, Alexandra K Tsaroucha, Panos Prassopoulos, Constantinos Simopoulos

Erschienen in: BMC Gastroenterology | Ausgabe 1/2003

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Primary adenocarcinomas of the appendix are uncommon. Mucoceles that result from mucinous adenocarcinomas of the appendix may be incidentally detected on imaging.

Case presentation

A case of a mucocele of the appendix, due to cystadenocarcinoma, is presented as an incidental imaging finding in a female, 86-year-old patient. The patient was admitted due to rectal hemorrhage and underwent colonoscopy, x-ray, US and CT. Adenocarcinoma of the ascending colon, adenomatous polyp of the sigmoid colon and a cystic lesion in the right iliac fossa were diagnosed. The cystic lesion was characterized as mucocele. The patient underwent right hemicolectomy, excision of the mucocele and sigmoidectomy. She recovered well and in two-year follow-up is free from cancer.

Conclusions

Preoperative diagnosis of an underlying malignancy in a mucocele is important for patient management, but it is difficult on imaging studies. Small lymph nodes or soft tissue stranding in the surrounding fat on computed tomography examination may suggest the possibility of malignancy.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-230X-3-30) contains supplementary material, which is available to authorized users.

Competing interests

None declared.

Authors' contributions

All authors contributed equally to this work. All authors read and approved the final manuscript.

Background

Primary adenocarcinoma of the appendix is uncommon [1]. On gross examination this tumor may be presented as mucocele. Although there are many pathology reports of primary cystadenocarcinoma of the appendix, only a limited number of cases have appeared in the radiology or surgical literature [26]. Preoperative diagnosis is difficult but important for surgical management. We present a case of primary cystadenocarcinoma of the appendix occurring concurrently with adenocarcinoma of the colon.

Case report

An 86-year-old female was admitted to our hospital with rectal hemorrhage. A sessile polyp of the sigmoid colon and a tumor of the ascending colon were detected by colonoscopy. Plain film of the abdomen demonstrated a soft tissue mass with peripheral calcifications (Figure 1) in the right iliac fossa. Mucocele of the appendix and echinococcus cyst were included in the differential diagnosis. Ultrasonography also showed the lesion (Figure 2) to be more consistent with a mucocele of the appendix. Staging Computed Tomography (CT) examination of the abdomen, demonstrated a cystic space occupying lesion in the right iliac fossa. The lesion measuring 7 cm in maximum diameter showed calcification in the wall (Figure 3). Two small soft tissue nodules were also identified close to the posterior margin of the lesion (Figure 4) with minimal soft tissue density strands in the surrounding fat. There was no ascites or other abnormality in the peritoneum. The cystic lesion was considered a mucocele of the appendix and the finding in the surrounding fat suggested the possibility of an underlying malignancy. In close proximity with the ileocecal valve, CT showed a large tumor mass in the ascending colon (Figure 5) while the terminal ileum was partially invaginated into the cecum.
The patient underwent right hemicolectomy, excision of the mucocele and sigmoidectomy (Figures 6 and 7). On gross examination, the mucocele was filled with gelatinous material. The histological diagnosis was cystadenocarcinoma of the appendix with evidence of glandular invasion into the stroma and positive lymph nodes. The tumor mass in the ascending colon was a well-differentiated adenocarcinoma of the large intestine, and similarly, the polyp in the sigmoid colon was a well-differentiated infiltrating adenocarcinoma arising in an adenomatous polyp with severe epithelial dysplasia.

Discussion

Mucocele of the appendix is a descriptive term for mucinous distension of the appendiceal lumen, regardless of the underlying pathology. The incidence of mucocele in appendectomy specimens is about 0.25% [7]. The male to female ratio is 1:4 with a mean age of 55 years at diagnosis [7]. The most common symptom is right lower abdominal pain mimicking appendicitis, although mucocele can also be asymptomatic, as in our patient, found incidentally on imaging [2, 6]. In our case the underlying pathology proved to be a mucinous cystadenocarcinoma of the appendix. Primary adenocarcinoma of the appendix is uncommon, occurring in 0.08% of all appendectomies [1]. Mucinous cystadenocarcinoma is usually a well-differentiated neoplasm, and the gross morphology of this tumor is that of a mucocele [2]. Although there are many pathology reports of primary mucinous cystadenocarcinoma, only a few cases have been reported in the radiology literature [25]. Preoperative diagnosis, although important for proper surgical management, is difficult due to the absence of specific imaging findings. The presence of a cystic mass in the expected area of the appendix with enhancing wall and nodularity on CT examination suggests the possibility of mucinous cystadenocarcinoma [24, 8]. Wall thickness has not been proven to be a reliable differential point between neoplastic and non-neoplastic causes of mucocele of the appendix [3], thus the presence of relatively thin wall in our case can not exclude malignancy. Curvilinear nodular or punctuate wall calcifications, as in our case, have been reported in both malignant and benign mucoceles [2, 3].
In our case, the two very small nodules present close to the wall of the mucocele were consistent with lymph nodes. This finding along with minimal stranding in the surrounding fat may be suggestive of a malignant lesion and should be carefully evaluated as an aid in the differential diagnosis. The cystadenocarcinoma of the appendix was associated with an adenocarcinoma of the ascending colon and an adenomatous polyp with malignant transformation of the sigmoid colon. There have been reports of other tumors associated with adenomatous change in the appendix, including the gastrointestinal tract, ovary, breast and kidney [6]. However, the most common association was with adenocarcinoma of the colon. Indeed, 21.4% of a series of appendiceal adenomas were associated with colon neoplasia [6]. A common underlying cause is suggested, since the histological features of appendiceal adenocarcinomas are identical to those of adenocarcinomas elsewhere in the large bowel [6]. Considering that the appendix is a part of the large intestine, adenomatous polyps, papillary adenomas and adenocarcinomas in the appendix are simply an expression of colonic neoplasms in this particular anatomic location. Thus, low incidence of mucoceles is attributed to the relatively small size of the appendix in comparison to the rest of the large bowel [6].
Mucoceles are often an incidental finding on imaging examination of the abdomen. Small lymph nodes or stranding in the surrounding fat on CT may arise the possibility of a malignant underlying lesion. In these cases a thorough search for other colonic neoplasms is essential.

Acknowledgements

We thank the patient for giving us written consent for publishing this study.

Competing interests

None declared.

Authors' contributions

All authors contributed equally to this work. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Collins DC: A study of 50,000 specimens of the human vermiform appendix. Surg Gynecol Obstet. 1955, 101: 435-437. Collins DC: A study of 50,000 specimens of the human vermiform appendix. Surg Gynecol Obstet. 1955, 101: 435-437.
2.
Zurück zum Zitat Lim HK, Lee WJ, Kim SH, Kim B, Cho JM, Byun JY: Primary mucinous cystadenocarcinoma of the appendix: CT findings. AJR. 1999, 173: 1071-1074.CrossRefPubMed Lim HK, Lee WJ, Kim SH, Kim B, Cho JM, Byun JY: Primary mucinous cystadenocarcinoma of the appendix: CT findings. AJR. 1999, 173: 1071-1074.CrossRefPubMed
3.
Zurück zum Zitat Kim SH, Lim HK, Lee WJ, Lim JH, Byun JY: Mucocele of the appendix: Ultrasonographic and CT findings. Abdominal Imaging. 1998, 23: 292-296. 10.1007/s002619900343.CrossRefPubMed Kim SH, Lim HK, Lee WJ, Lim JH, Byun JY: Mucocele of the appendix: Ultrasonographic and CT findings. Abdominal Imaging. 1998, 23: 292-296. 10.1007/s002619900343.CrossRefPubMed
4.
Zurück zum Zitat Madwed D, Mindelzum R, Jeffrey RB: Mucocele of the appendix: Imaging findings. AJR. 1992, 159: 69-72.CrossRefPubMed Madwed D, Mindelzum R, Jeffrey RB: Mucocele of the appendix: Imaging findings. AJR. 1992, 159: 69-72.CrossRefPubMed
5.
Zurück zum Zitat Dachman AH, Lichtenstein JE, Friedman AC: Mucocele of the appendix and pseudomyxoma peritonei. AJR. 1985, 144: 923-929.CrossRefPubMed Dachman AH, Lichtenstein JE, Friedman AC: Mucocele of the appendix and pseudomyxoma peritonei. AJR. 1985, 144: 923-929.CrossRefPubMed
6.
Zurück zum Zitat Wolff M, Ahmed N: Epithelial neoplasms of the vermiform appendix (exclusive of carcinoid): II. Cystadenomas, papillary adenomas, and polyps of the appendix. Cancer. 1976, 37: 2511-2522.CrossRefPubMed Wolff M, Ahmed N: Epithelial neoplasms of the vermiform appendix (exclusive of carcinoid): II. Cystadenomas, papillary adenomas, and polyps of the appendix. Cancer. 1976, 37: 2511-2522.CrossRefPubMed
7.
Zurück zum Zitat Aho AJ, Heinonen R, Lauren P: Benign and malignant mucocele of the appendix. Acta Chir Scand. 1973, 139: 392-400.PubMed Aho AJ, Heinonen R, Lauren P: Benign and malignant mucocele of the appendix. Acta Chir Scand. 1973, 139: 392-400.PubMed
8.
Zurück zum Zitat Pickhardt PF, Levy AD, Rohrmann CA, Kende AI: Primary neoplasms of the appendix: Radiologic spectrum of disease with pathologic correlation. RadioGraphics. 2003, 23: 645-662.CrossRefPubMed Pickhardt PF, Levy AD, Rohrmann CA, Kende AI: Primary neoplasms of the appendix: Radiologic spectrum of disease with pathologic correlation. RadioGraphics. 2003, 23: 645-662.CrossRefPubMed
Metadaten
Titel
Cystadenocarcinoma of the appendix: an incidental imaging finding in a patient with adenocarcinomas of the ascending and the sigmoid colon
verfasst von
Michail Pitiakoudis
Paraskevi I Argyropoulou
Alexandra K Tsaroucha
Panos Prassopoulos
Constantinos Simopoulos
Publikationsdatum
01.12.2003
Verlag
BioMed Central
Erschienen in
BMC Gastroenterology / Ausgabe 1/2003
Elektronische ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-3-30

Weitere Artikel der Ausgabe 1/2003

BMC Gastroenterology 1/2003 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

NSCLC: Progressionsfreies Überleben unter Osimertinib fast versiebenfacht

06.06.2024 ASCO 2024 Kongressbericht

Erste Ergebnisse der Phase-III-Studie LAURA etablieren Osimertinib als neuen Therapiestandard für Menschen mit nicht-resezierbarem, EGFR-mutiertem, nicht-kleinzelligem Lungenkarzinom im Stadium III, die nach definitiver Radiochemotherapie progressionsfrei sind. Auf der ASCO-Tagung wurden diese beeindruckenden Ergebnisse besprochen.

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gute molekulare Response, aber seltener ernste Nebenwirkungen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.